SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) Stock Fundamental Analysis

TSX-V:HASH • CA82888A1021

0.13 CAD
-0.01 (-3.7%)
Last: Feb 24, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HASH. HASH was compared to 33 industry peers in the Pharmaceuticals industry. HASH has a bad profitability rating. Also its financial health evaluation is rather negative. HASH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year HASH was profitable.
  • HASH had a negative operating cash flow in the past year.
HASH.CA Yearly Net Income VS EBIT VS OCF VS FCFHASH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

  • With an excellent Return On Assets value of 6.91%, HASH belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
  • The Return On Equity of HASH (13.05%) is better than 84.85% of its industry peers.
Industry RankSector Rank
ROA 6.91%
ROE 13.05%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HASH.CA Yearly ROA, ROE, ROICHASH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

  • HASH has a better Profit Margin (13.57%) than 84.85% of its industry peers.
  • HASH has a Gross Margin of 28.99%. This is comparable to the rest of the industry: HASH outperforms 45.45% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 13.57%
GM 28.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HASH.CA Yearly Profit, Operating, Gross MarginsHASH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • HASH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HASH has more shares outstanding
  • The debt/assets ratio for HASH is higher compared to a year ago.
HASH.CA Yearly Shares OutstandingHASH.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
HASH.CA Yearly Total Debt VS Total AssetsHASH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10M 20M 30M

2.2 Solvency

  • HASH has an Altman-Z score of 1.20. This is a bad value and indicates that HASH is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.20, HASH is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • HASH has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • HASH's Debt to Equity ratio of 0.38 is in line compared to the rest of the industry. HASH outperforms 48.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC8.23%
HASH.CA Yearly LT Debt VS Equity VS FCFHASH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • HASH has a Current Ratio of 2.53. This indicates that HASH is financially healthy and has no problem in meeting its short term obligations.
  • HASH has a better Current ratio (2.53) than 63.64% of its industry peers.
  • HASH has a Quick Ratio of 2.53. This is a bad value and indicates that HASH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HASH's Quick ratio of 0.74 is on the low side compared to the rest of the industry. HASH is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 0.74
HASH.CA Yearly Current Assets VS Current LiabilitesHASH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • HASH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -410.40%.
  • The Revenue has grown by 120.93% in the past year. This is a very strong growth!
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.83%
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HASH.CA Yearly Revenue VS EstimatesHASH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • HASH is valuated cheaply with a Price/Earnings ratio of 6.50.
  • 90.91% of the companies in the same industry are more expensive than HASH, based on the Price/Earnings ratio.
  • HASH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.98.
Industry RankSector Rank
PE 6.5
Fwd PE N/A
HASH.CA Price Earnings VS Forward Price EarningsHASH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HASH.CA Per share dataHASH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HASH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SIMPLY SOLVENTLESS CONCENTRA

TSX-V:HASH (2/24/2026, 7:00:00 PM)

0.13

-0.01 (-3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-27
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.22%
Ins Owner ChangeN/A
Market Cap15.02M
Revenue(TTM)30.71M
Net Income(TTM)4.17M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.5
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.47
P/tB 0.76
EV/EBITDA N/A
EPS(TTM)0.02
EY15.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.27
BVpS0.28
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.35
Profitability
Industry RankSector Rank
ROA 6.91%
ROE 13.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.57%
GM 28.99%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.7%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.53
Quick Ratio 0.74
Altman-Z 1.2
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-302.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1009.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1332.95%
OCF growth 3YN/A
OCF growth 5YN/A

SIMPLY SOLVENTLESS CONCENTRA / HASH.CA FAQ

What is the fundamental rating for HASH stock?

ChartMill assigns a fundamental rating of 2 / 10 to HASH.CA.


What is the valuation status of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to SIMPLY SOLVENTLESS CONCENTRA (HASH.CA). This can be considered as Overvalued.


How profitable is SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) has a profitability rating of 3 / 10.


Can you provide the financial health for HASH stock?

The financial health rating of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) is 3 / 10.